Vegas Lawyer
Helping People Who
Were Hurt In Nevada

Dempsey, Roberts
& Smith, Ltd.
Attorneys-At-Law




Vegas Personal
Injury Lawyer

Nevada Legal Help


Home
Mesothelioma
Slip & Fall
Medical Injury
Product Defect
Other Claims
Articles
Contact Us
















Las Vegas Personal Injury Lawyer

Vegas Injury Law

Las Vegas Inury Lawyer
vegaslawyer.net

  • Postmarketing Drug Surveillance














  • Postmarketing Drug Surveillance


    Postmarketing drug surveillance could be improved

    There is no systematic coherent approach for evaluating the long-term safety of drugs once they have been approved for marketing by the U.S. Food and Drug Administration (FDA), according to Marie R. Griffin, M.D., M.P.H., and her colleagues at the Vanderbilt University Center for Research and Education on Therapeutics (CERT), which is supported by the Agency for Healthcare Research and Quality (HS10384).

    Before drug companies can market a new drug, it must undergo extensive testing and rigorous evaluation by the FDA. However, these studies are necessarily limited as to numbers of patients and duration of followup. Therefore, a very important part of the experiment begins after the product is approved and a much larger number of patients begin to use it. During this postmarketing period, a system of voluntary reporting is relied on to detect potential problems.

    In addition to voluntary reporting, the FDA may ask a manufacturer to conduct a "phase 4" or postmarketing study before or after licensure if additional information is needed to improve prescribing. Yet, companies often don't conduct these studies. As of February 2002, only 37 percent of the 2,400 postmarketing commitments for new drugs had been completed, and many had never been started.

    On the other hand, manufacturers may not be the best group to evaluate postmarketing safety, according to a recent commentary by Dr. Griffin and her colleagues. Many experts agree that the major problem with the current system is the lack of an independent organization responsible for the systematic review of drugs for safety after marketing. In the last 5 years, seven CERTs and a CERTs coordinating center have been established, in part to galvanize more interest in and support for postmarketing drug studies. The CERTs program, which is administered by AHRQ, involves collaboration across all sectors—public and private, industry and government, academia and business—to improve the use of medicines and medical devices.

    See "Postmarketing surveillance for drug safety: Surely we can do better," by Dr. Griffin, C. Michael Stein, M.D., and Wayne A. Ray, Ph.D., in the June 2004 Clinical Pharmacology & Therapeutics 75(6), pp. 491-494.

    This information came from an AHRQ online article.

    *** Any law, statute, regulation or other precedent is subject to change at any time ***

    Index | Home

    Contact David Matheny, Esq. for a free consultation.

    (702) 388-1229




    Lawyer Search | Attorney Finder


    Search for more information on Vegas Law and Las Vegas Lawyers:

       




    Las Vegas Legal Help
    Nevada Injury Law


















    Vegas Lawyer
    Vegas Lawyers

    Index | Home

    Find A Lawyer By State | Search For Attorneys By City | Get Legal Information | Contact Us





    DEMPSEY, ROBERTS & SMITH, LTD.
    520 South Fourth Street, Suite 360
    Las Vegas, Nevada 89101

    Las Vegas Lawyer - Las Vegas Attorney - Las Vegas Personal Injury Lawyer

    Neither the State Bar of Nevada nor any agency of the State Bar has certified any lawyer identified here as a specialist or as an expert.  Anyone considering a lawyer should independently investigate the lawyer's credentials and ability. This site is intended for Nevada residents and those with legal issues arising under the jurisdiction of the State of Nevada.  This site does not give legal advice or create an attorney-client relationship.  Laws are different in other states and localities, consult a local attorney.

    The information in this web site is provided for informational purposes only. The information does not constitute legal advice. The use of this site does not create an attorney-client relationship. Further communication with an attorney through the web site and e-mail may not be considered as confidential or privileged. Please contact our attorneys if you wish to discuss the contents of this web site. Any laws, rules or statutes giving any information, restrictions or deadlines, are always subject to change at any time - Contact a local attorney to obtain the current status of such information.

    In the series of Articles on this site, many government PSAs and other information are excerpted. All such materials are believed to be in the public domain. If any work is protected, contact the webmaster at any of the e-mail links and the material will be taken off the site immediately.

    If you experience unusual problems with this site or discover bad links, please email the webmaster. Thank you.

    Copyright: David Matheny, 2003-2005.